Reducing tobacco use in people with HIV
Part of Infections, Lungs & breathing clinical trials.
This study combines a medication to help people stop smoking with a custom mobile app, all within the Swiss HIV Cohort Study. It's designed for people living with HIV who smoke and want to quit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must smoke at least one real cigarette every day.
- You cannot be using e-cigarettes, nicotine pouches, or nicotine patches right now.
- You cannot be pregnant.
- You must have already agreed to be part of the Swiss HIV Cohort Study and to be randomly assigned to treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program that helps people with HIV quit smoking by combining medication, counseling, and financial rewards. It aims to see if this approach works well in HIV clinics and helps reduce smoking.
This trial tests smoking-cessation interventions to help people living with HIV quit smoking or smoke less. You may be eligible if you smoke, are actively engaged in HIV treatment, and can follow the study for about a year.
This study tests a harm-reduction approach to help people with HIV smoke fewer cigarettes and quit if they want, using an online tobacco program and varenicline (a quit-smoking medicine). You may be placed in one of two different study groups to compare how well the approaches work.
This study tests a program to help Lao people living with HIV quit smoking. The program provides support and is designed to see if it helps you stay smoke-free.
This study tests a combination of counseling and medication to help people with HIV stop smoking and cut down on heavy drinking. It aims to improve overall health and quality of life.
This trial tests ways to deliver tobacco-quit treatment more effectively for people living with HIV. You may help researchers compare different quit-support approaches to see what works best.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.